Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Jul 18;12(14):e029670.
doi: 10.1161/JAHA.123.029670. Epub 2023 Jul 14.

Role of ST-Segment Resolution Alone and in Combination With TIMI Flow After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction

Affiliations
Clinical Trial

Role of ST-Segment Resolution Alone and in Combination With TIMI Flow After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction

Chao Wu et al. J Am Heart Assoc. .

Abstract

Background To evaluate the role of ST-segment resolution (STR) alone and in combination with Thrombolysis in Myocardial Infarction (TIMI) flow in reperfusion evaluation after primary percutaneous coronary intervention (PPCI) for ST-segment-elevation myocardial infarction by investigating the long-term prognostic impact. Methods and Results From January 2013 through September 2014, we studied 5966 patients with ST-segment-elevation myocardial infarction enrolled in the CAMI (China Acute Myocardial Infarction) registry with available data of STR evaluated at 120 minutes after PPCI. Successful STR included STR ≥50% and complete STR (ST-segment back to the equipotential line). After PPCI, the TIMI flow was assessed. The primary outcome was 2-year all-cause mortality. STR < 50%, STR ≥50%, and complete STR occurred in 20.6%, 64.3%, and 15.1% of patients, respectively. By multivariable analysis, STR ≥50% (5.6%; adjusted hazard ratio [HR], 0.45 [95% CI, 0.36-0.56]) and complete STR (5.1%; adjusted HR, 0.48 [95% CI, 0.34-0.67]) were significantly associated with lower 2-year mortality than STR <50% (11.7%). Successful STR was an independent predictor of 2-year mortality across the spectrum of clinical variables. After combining TIMI flow with STR, different 2-year mortality was observed in subgroups, with the lowest in successful STR and TIMI 3 flow, intermediate when either of these measures was reduced, and highest when both were abnormal. Conclusions Post-PPCI STR is a robust long-term prognosticator for ST-segment-elevation myocardial infarction, whereas the integrated analysis of STR plus TIMI flow yields incremental prognostic information beyond either measure alone, supporting it as a convenient and reliable surrogate end point for defining successful PPCI. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01874691.

Keywords: ECG; acute myocardial infarction; outcome; reperfusion.

PubMed Disclaimer

Figures

Figure 1
Figure 1. A flowchart for subject selection.
AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; CAMI, China Acute Myocardial Infarction; NSTEMI, non–ST‐segment–elevation myocardial infarction; PPCI, primary percutaneous coronary intervention; STEMI, ST‐segment–elevation myocardial infarction; and STR, ST‐segment resolution.
Figure 2
Figure 2. Kaplan‐Meier curves for the 2‐year all‐cause mortality.
A, According to ST‐segment resolution (STR). B, According to concordant/discordant STR and Thrombolysis in Myocardial Infarction (TIMI) flow. Log‐rank test: P<0.001. Successful STR (SS) included STR ≥50% and complete STR.
Figure 3
Figure 3. Unadjusted hazard ratios (HRs) for the 2‐year all‐cause mortality according to clinical or angiographic subgroups.
*Successful ST‐segment resolution (STR) included STR ≥50% and complete STR. GPI indicates glycoprotein IIb/IIIa inhibitor; LVEF, left ventricular ejection fraction; and PCI, percutaneous coronary intervention.

References

    1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20. doi: 10.1016/S0140-6736(03)12113-7 - DOI - PubMed
    1. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al. 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362–e425. doi: 10.1161/CIR.0b013e3182742cf6 - DOI - PubMed
    1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli‐Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST‐segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39:119–177. doi: 10.1093/eurheartj/ehx393 - DOI - PubMed
    1. Niccoli G, Scalone G, Lerman A, Crea F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37:1024–1033. doi: 10.1093/eurheartj/ehv484 - DOI - PubMed
    1. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no‐reflow in humans. J Am Coll Cardiol. 2009;54:281–292. doi: 10.1016/j.jacc.2009.03.054 - DOI - PubMed

Publication types

Associated data